Please note: Any medical or genetic information present in this entry is not intended as a diagnosis of your problem, but rather is provided as a helpful guide for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. Information is not necessarily complete. Please see your doctor for diagnosis and treatment.

Please note: DNAtraffic database is the project under construction and information on this page is not finished yet.

Stepronin


ACCESSION NB: DB01423


TYPE: small molecule


GROUP: approved


DESCRIPTION:
Strepronin is a mucolytic drug. A mucolytic agent is any agent which dissolves thick mucus usually used to help relieve respiratory difficulties. The viscosity of mucous secretions in the lungs is dependent upon the concentrations of mucoprotein as well as the presence of disulfide bonds between these macromolecules and DNA.

VOLUME OF DISTRIBUTION: Not Available

CATEGORIES:
Antiviral Agents Immunosuppressive Agents Expectorants

ABSORPTION: Not Available

INDICATION:
Strepronin is a mucolytic (expectorant) drug.

PHARMACODYNAMICS:
The drug promotes drainage of mucus from the lungs by thinning the mucus and lubricating the irritated respiratory tract

MECHANISM OF ACTION:
An expectorant increases bronchial secretions and mucolytics help loosen thick bronchial secretions. Expectorants reduce the thickness or viscosity of bronchial secretions thus increasing mucus flow that can be removed more easily through coughing, Mucolytics break down the chemical structure of mucus molecules. The mucus becomes thinner and can be removed more easily through coughing.

PROTEIN BINDING:
Not Available

TOXICITY:
Not Available

AFECTED ORGANISMS:
Humans and other mammals